The US Food and Drug Administration (FDA) has approved neffy (epinephrine nasal spray) for the emergency treatment of al...
Taiwan-based Formosa Pharmaceuticals has signed a non-binding terms agreement with US-based Eyenovia, Inc., whereby the ...
Kyowa Kirin International (KKI), a wholly owned subsidiary of Japan-based Kyowa Kirin Co., has announced the signing of ...
GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved a new indication for Jemperl...
Japan-based pharma firm Daiichi Sankyo and global life sciences company Merck, known as MSD outside of the United States...
Department of Health – Abu Dhabi (DoH) has provided revolutionary gene transfer therapy for Duchenne muscular dyst...
Australia is stepping up to the global fight against antimicrobial resistance, as Pfizer Australia announces a major upg...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Canadian firm Apotex Inc., f...
Japan-based Otsuka Pharmaceutical Co. and Jnana Therapeutics Inc. have entered into a definitive merger agreement ...
Kyowa Kirin Asia Pacific, a wholly owned subsidiary of Japan-based Kyowa Kirin Co., has announced plans to transform its...
Ireland-based Almac Clinical Services has announced a significant investment to develop a new frozen facility in Singapo...
As more biologics lose patent protection, over $200 billion worth of innovator biologics are set to go off-patent by 203...
How does your flagship product iQ-Solutions leverage AI to provide analysis of the brain? IQ stands for intelligent qua...
Can you tell us about NeuroSigma? NeuroSigma is a Los Angeles, California-based bioelectronic medical device company de...
The Commonwealth Government’s Medical Research Future Fund (MRFF) has invested $4 million into establishing Austra...
Taiwan-based startup Merdury Biopharmaceutical Corporation has signed a Memorandum of Understanding (MoU) with Health2Sy...
Japanese firms Eisai Co. and EcoNaviSta Inc. have entered into a business alliance agreement and commenced collaboration...
BeiGene, a China-based oncology company, has announced the opening of its flagship US facility in Hopewell, New Jersey, ...
Japan-headquartered pharma firm Eisai Co. has entered into a license agreement regarding the development and commerciali...
Pfizer Inc. unveiled its new highly automated Active Pharmaceutical Ingredient (API) manufacturing facility in Tuas...
Japan-headquartered Astellas Pharma Inc. and Graduate School of Medicine / Faculty of Medicine, Osaka University ha...
ADM Korea, a subsidiary of Hyundai Bioscience, has announced that the first clinical trial target population for its nic...
Eisai Co. and Biogen Inc. have announced that the Department of Health in Hong Kong has approved humanised anti-soluble ...
GSK plc and Medicines for Malaria Venture (MMV) have announced that the first single-dose medicine for the prevent...
June 2024 has been a tumultuous month for the biopharma and biotech industries, marked by significant layoffs across sev...
